Hermeus' $350M Series C: Why Angels Are Rotating Into Defense Tech
Hermeus' $350M Series C signals a major venture capital shift from GenAI toward defense-adjacent deep tech. Backed by Vinod Khosla and L3Harris partnerships, hypersonic aircraft funding offers DoD contracts and derisked revenue models.
April 8, 2026
Private Credit Interval Fund Wealth Management Access
Private credit interval funds provide accredited investors with semi-liquid access to institutional-grade credit strategies through quarterly redemption windows, eliminating traditional $10M+ minimums.
April 8, 2026
DOL ERISA Alternative Investments 401k Rule 2026
The Department of Labor's March 30, 2026 proposed rule fundamentally reshapes how 401(k) plan fiduciaries can evaluate and allocate to alternative investments including private credit, venture capital, and LP secondaries.
April 8, 2026
Hermeus Series C: Why Defense-Tech Became Venture's New Frontier
Hermeus, an Atlanta-based hypersonic aircraft startup, raised $350 million in Series C funding at a $1 billion valuation with backing from Vinod Khosla, marking a major shift in venture capital toward defense infrastructure and away from consumer AI.
April 8, 2026
SEC Reg Crypto Safe Harbor Advances: Startup Exemption
The SEC's Reg Crypto proposal has advanced to final White House review, offering early-stage blockchain startups a new $5M fundraising exemption over four years without traditional securities registration requirements.
April 8, 2026
Angel Investor Syndicate Seed Funding Soars in 2026
Angel investor syndicates have evolved from solo check writers to institutional-speed networked groups, co-leading major seed rounds like Miravoice's $6.3M funding in April 2026.
April 8, 2026
Private Credit Interval Fund Liquidity 2026: Why LPs Want Exit Ramps
Morgan Stanley's interval fund filing signals a structural shift in private credit allocation. LPs now demand quarterly redemption options, breaking the traditional 10-year lockup model.
April 8, 2026
African Tech Seed Funding: How Diaspora Capital and Local VCs Are Reshaping the Continent
African tech fundraising is no longer dependent on foreign VCs. Diaspora-backed venture firms, local institutional investors, and corporate venture arms now dominate seed and Series A. Founders in Lagos, Nairobi, Accra have more local capital options than ever.
April 8, 2026
Multifamily Operators Growth Stage: Capital Raising to Expand Your Portfolio
Multifamily operators scaling from single-asset syndications to multi-property platforms require institutional capital ($50M+). Growth-stage multifamily markets are stabilizing in 2026 after supply-driven adjustment; capital flows returning to experienced operators.
April 8, 2026
DeFi Protocol Seed Funding: Why Regulatory Clarity Now Unlocks Institutional Capital
DeFi protocol fundraising shifted in 2025. Institutional investors (pensions, insurance, endowments) now participate in protocols that demonstrate regulatory compliance. Total DeFi TVL exceeded $200B in Oct 2025; institutional participation remains low but growing.
April 8, 2026
Healthtech FDA-Pending Capital Raising: Navigating Regulatory Uncertainty While Fundraising
Healthtech investors care about regulatory de-risking more than feature launches. Your capital story is: here's the pathway to FDA approval, here's our probability of success, here's what approval enables in revenue.
April 8, 2026
B2B SaaS Pre-Product Fundraising: How to Raise Without Revenue (And Why Investors Do It)
Pre-product SaaS fundraising is possible but conditional. Investors fund the team and problem clarity, not the product. You need: founder credibility from previous exits or roles, a clearly defined customer problem, and large addressable market.
April 8, 2026